KA/EN
Register
Medicines reference
Search
Search
Active substance

Chlorhexidine

Favourites

Bisbiguanide antiseptic. Registered in Georgia: 4 veterinary products and 1 human medicine. Forms: cream, drops (oral), solution, topical (unspecified).

Dose and use

Doses

We have no dose with a cited source for this substance yet.

Before use

Safety information

Known Contraindications

  • Critical
    Do not use in cases of hypersensitivity to the active substances or to any of the excipients. Exceptionally in dogs with atopy or cats with allergic skin disease.
    Sources: VMD SPC · VMD
Latin name
Chlorhexidine
Georgian name
ქლორჰექსიდინი
Authorisation status
Authorised veterinary medicine
An authorised veterinary medicine containing this substance exists. Whether a particular use is on-label depends on the species and the indication - see each dose rule.
Registered in Georgia
5 of 5 forms
Products
AdoEQMINA, Bepanthen Plus, CitoDerm, Diamond Eyes, OKVET
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
All forms and registration5

Registration in Georgia and abroad: the register, number, validity and source are behind (i).

AdoEQMINA 10 mg/ml, Topical (unspecified)

chlorhexidine gluconate, cutaneous solution
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Label-concordant cutaneous disinfection of skin, erosions, small superficial wounds, mild burns and abrasions
7.3/10
Good
vetman assessment

AdoEQMINA

10 mg/ml, chlorhexidine gluconate, cutaneous solution
Assessed clinical scopeDog · Label-concordant cutaneous disinfection of skin, erosions, small superficial wounds, mild burns and abrasions · On the skin
Care settingVeterinary-assessed small-lesion care with clinic or instructed home dabbing and reassessment
vetman score 7.3/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · Verified on 22 Oct 2026

A transparent, authorised and practical 1% chlorhexidine solution for selected small superficial skin lesions. It benefits from strong canine chlorhexidine plausibility but not exact-product outcome data; its explicit eye, ear, mucosal, deep-wound and puncture-site exclusions are essential.

Regulatory and scientific credibility8.0/10

The exact 10 mg/ml composition, complete current Spanish SPC, valid EU/EEA authorisation 384 ESP, marketed 70 ml presentation and exact Georgian registration are verifiable. Independent exact-product dog/cat outcomes are absent, but legal status and formulation boundaries are transparent.

Clinical efficacy6.5/10

Chlorhexidine has strong canine topical-antiseptic support, including guideline and field evidence, and the exact product has a coherent small-lesion label. Most direct canine evidence uses 2–4% shampoo/spray or preoperative protocols, not this undiluted 1% dabbing solution; it cannot establish identical pyoderma efficacy or override the label’s puncture-site/deep-wound exclusions.

Safety and tolerability7.0/10

Minimal skin absorption and low expected oral toxicity support a favourable small-field profile. Safety is limited by unknown-frequency dermatitis, photosensitivity and hypersensitivity, explicit ocular/aural/mucosal and deep-wound exclusions, anionic-detergent incompatibility and concentration/exposure-dependent tissue toxicity.

Clinical practicality8.0/10

The 70 ml ready-to-use solution needs no dilution or special equipment: clean, dry and dab with a soaked cotton swab once daily. Practicality is reduced by the absence of a fixed volume/course and by the need for veterinary judgment before more-frequent use, drying and reassessment.

Full-course cost-effectiveness-

Current Georgian pack price and comparable full-course costs were unavailable; price is excluded from the denominator.

Important safety and use flags

  • Hard stop: do not use with chlorhexidine or excipient hypersensitivity. Stop and reassess dermatitis, photosensitivity, urticaria, facial swelling, dyspnoea or another local/systemic hypersensitivity reaction.
  • Strict route boundary: external skin only. Never use in eyes, ears/ear canals, mouth, another mucosa or body cavity; do not use as a lavage. Immediately rinse accidental eye, ear or mucosal contact with abundant clean water and assess persistent irritation or neurological/vestibular signs.
  • Strict scope boundary: not for deep or extensive wounds, puncture/injection-site asepsis or surgical-instrument disinfection. Evidence from surgical preparation, ear products, shampoos or higher chlorhexidine concentrations does not override the exact label.
  • Exact technique: use undiluted; clean and dry the small area, soak a cotton swab and dab once daily. Use more often only when the veterinarian considers it appropriate. No universal volume or course duration is stated—do not pour, irrigate, spray, inject or invent an open-ended regimen.
  • Wound care is broader than antisepsis. Provide analgesia, lavage, debridement, drainage, foreign-body removal, dressing/closure planning, culture and systemic treatment when indicated. Worsening pain, swelling, discharge, necrosis, fever or delayed healing requires reassessment.
  • Prevent licking and contact among animals until the coat/site is completely dry; nursing offspring must not contact a treated lactating female before drying. Cats require particular control of grooming and paw-to-eye/ear transfer.
  • Repeated long-term use can cause dermatitis, and photosensitivity/hypersensitivity have unknown frequency. Use the smallest appropriate field and duration; stop and reassess irritation or failure rather than increasing frequency indefinitely.
  • Major incompatibility: anionic detergents can inactivate chlorhexidine. Rinse/sequence cleaning products appropriately and do not layer another antiseptic, wound product or dressing preparation without verified compatibility.
  • The exact label describes no pregnancy/lactation contraindication, but no controlled exact-product dog/cat reproductive outcome study was identified. Use repeated or extensive treatment only after explicit benefit–risk assessment, and enforce the nursing-offspring drying rule.
  • Handler/storage: chlorhexidine-hypersensitive people should avoid contact; protect eyes, do not eat/drink/smoke during handling and wash hands afterwards. Keep chlorhexidine-contaminated white fabric away from bleach to avoid permanent staining. The opened bottle is usable for one year when correctly stored.
Assessment sources
  1. AEMPS AdoEQMINA exact2023
  2. NFA AdoEQMINA exact2026
  3. ISCAID canine pyoderma guideline2025
  4. VMD Adaxio canine trial2025
  5. Veterinary asepsis SR2022
  6. MSD small-animal wounds2026
  7. Antiseptic cytotoxicity2023
  8. VMD Malaseb control2025
  9. FDA topical control2001
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant cutaneous disinfection of skin, erosions, small superficial wounds, mild burns and abrasions
6.7/10
Situational / acceptable
vetman assessment

AdoEQMINA

10 mg/ml, chlorhexidine gluconate, cutaneous solution
Assessed clinical scopeCat · Label-concordant cutaneous disinfection of skin, erosions, small superficial wounds, mild burns and abrasions · On the skin
Care settingVeterinary-assessed small-lesion care with clinic or instructed home dabbing and reassessment
vetman score 6.7/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · Verified on 22 Oct 2026

An authorised, controllable feline option for selected small superficial lesions, but direct cat outcomes are absent. Grooming and eye/ear transfer make it situational despite a simple cotton-swab technique and low systemic absorption.

Regulatory and scientific credibility8.0/10

The exact 10 mg/ml composition, complete current Spanish SPC, valid EU/EEA authorisation 384 ESP, marketed 70 ml presentation and exact Georgian registration are verifiable. Independent exact-product dog/cat outcomes are absent, but legal status and formulation boundaries are transparent.

Clinical efficacy5.5/10

The exact all-species label supports selected feline small skin lesions, and chlorhexidine antisepsis is plausible, but no direct feline or exact-product outcome study was identified. Canine shampoo, preoperative and in-vitro evidence cannot establish comparative feline benefit or deep-wound efficacy.

Safety and tolerability6.5/10

Minimal skin absorption and low expected oral toxicity are reassuring, but direct feline outcomes are absent and grooming, eye/ear transfer and repeated restraint add exposure risk. Unknown-frequency dermatitis, photosensitivity and hypersensitivity plus the explicit ocular/aural/mucosal exclusions require a narrower margin.

Clinical practicality7.0/10

A cotton-swab application is quieter and more controllable than aerosol spraying, but many cats still resist repeated lesion handling and readily groom the site. Daily use is feasible only when eye/ear transfer and licking can be prevented until fully dry; more-frequent use needs veterinary judgment.

Full-course cost-effectiveness-

Current Georgian pack price and comparable full-course costs were unavailable; price is excluded from the denominator.

Important safety and use flags

  • Hard stop: do not use with chlorhexidine or excipient hypersensitivity. Stop and reassess dermatitis, photosensitivity, urticaria, facial swelling, dyspnoea or another local/systemic hypersensitivity reaction.
  • Strict route boundary: external skin only. Never use in eyes, ears/ear canals, mouth, another mucosa or body cavity; do not use as a lavage. Immediately rinse accidental eye, ear or mucosal contact with abundant clean water and assess persistent irritation or neurological/vestibular signs.
  • Strict scope boundary: not for deep or extensive wounds, puncture/injection-site asepsis or surgical-instrument disinfection. Evidence from surgical preparation, ear products, shampoos or higher chlorhexidine concentrations does not override the exact label.
  • Exact technique: use undiluted; clean and dry the small area, soak a cotton swab and dab once daily. Use more often only when the veterinarian considers it appropriate. No universal volume or course duration is stated—do not pour, irrigate, spray, inject or invent an open-ended regimen.
  • Wound care is broader than antisepsis. Provide analgesia, lavage, debridement, drainage, foreign-body removal, dressing/closure planning, culture and systemic treatment when indicated. Worsening pain, swelling, discharge, necrosis, fever or delayed healing requires reassessment.
  • Prevent licking and contact among animals until the coat/site is completely dry; nursing offspring must not contact a treated lactating female before drying. Cats require particular control of grooming and paw-to-eye/ear transfer.
  • Repeated long-term use can cause dermatitis, and photosensitivity/hypersensitivity have unknown frequency. Use the smallest appropriate field and duration; stop and reassess irritation or failure rather than increasing frequency indefinitely.
  • Major incompatibility: anionic detergents can inactivate chlorhexidine. Rinse/sequence cleaning products appropriately and do not layer another antiseptic, wound product or dressing preparation without verified compatibility.
  • The exact label describes no pregnancy/lactation contraindication, but no controlled exact-product dog/cat reproductive outcome study was identified. Use repeated or extensive treatment only after explicit benefit–risk assessment, and enforce the nursing-offspring drying rule.
  • Handler/storage: chlorhexidine-hypersensitive people should avoid contact; protect eyes, do not eat/drink/smoke during handling and wash hands afterwards. Keep chlorhexidine-contaminated white fabric away from bleach to avoid permanent staining. The opened bottle is usable for one year when correctly stored.
Assessment sources
  1. AEMPS AdoEQMINA exact2023
  2. NFA AdoEQMINA exact2026
  3. Veterinary asepsis SR2022
  4. MSD small-animal wounds2026
  5. Antiseptic cytotoxicity2023
  6. VMD Malaseb control2025
  7. FDA topical control2001
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Chlorhexidine10 mg/ml
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
Laboratorios Calier S.A. · Spain
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ადოექმინა 10 მგ/მლ კანის ხსნარი
Verified on: 22 Oct 2026
 EU Yes, veterinary
№ 384 ESP
Verified on: 22 Oct 2026
 UK No
Verified on: 22 Oct 2026
 US No
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified Dogs/cats: skin, erosions, small superficial wounds, mild burns and abrasions only. Use undiluted; clean and dry, soak a cotton swab and dab once daily. Apply more often only on veterinary judgment. No universal volume or course duration is stated. Prevent licking/contact until dry.

Bepanthen Plus, Cream

dexpanthenol 50 mg/g + chlorhexidine dihydrochloride 5 mg/g, cream 30 g, human medicine
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Adjunctive topical care of a cleaned small superficial skin wound or abrasion with credible infection risk, after exclusion or separate management of deep injury, established infection and wounds requiring debridement, drainage or closure
5.0/10
Weak evidence support
vetman assessment

Bepanthen Plus

dexpanthenol 50 mg/g + chlorhexidine dihydrochloride 5 mg/g, cream 30 g, human medicine
Assessed clinical scopeDog · Adjunctive topical care of a cleaned small superficial skin wound or abrasion with credible infection risk, after exclusion or separate management of deep injury, established infection and wounds requiring debridement, drainage or closure · On the skin
Care settingVeterinarian-directed outpatient or inpatient use on a small accessible lesion with planned licking prevention, wound monitoring and escalation if healing or infection control is inadequate
vetman score 5.0/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, human · № რ-038463 · Verified on 22 Oct 2026 Off-label use

A weak, narrowly situational off-label option for a cleaned small superficial canine wound at infection risk. Chlorhexidine class evidence and exact human transparency support plausibility, but no exact-cream canine outcome or damaged-skin safety study justifies a stronger claim.

Regulatory and scientific credibility6.0/10

The exact 30 g human cream has transparent composition, current Georgian and EU human authorisations and current official labels; canine chlorhexidine guidance and studies provide a scientific bridge. It has no veterinary authorisation or exact-product dog dossier, and salt, concentration, vehicle and clinical-scope transfer is substantial.

Clinical efficacy4.0/10

Canine chlorhexidine data support topical antisepsis, including 0.5% healthy-skin and 0.05% wound-lavage evidence, while human dexpanthenol evidence supports a healing rationale. No canine trial tested exact Bepanthen Plus, dihydrochloride cream or the fixed combination; formulation-mismatched evidence caps efficacy at 4/10.

Safety and tolerability4.5/10

Exact human risks and excipients are transparent, and 14-day 0.5% chlorhexidine gluconate exposure did not disrupt measured barrier function in six healthy dogs. Open/damaged skin, dihydrochloride cream, licking, lanolin/contact allergy and repeated-use tolerance remain untested; chlorhexidine is dangerous to the cornea.

Clinical practicality6.0/10

The ready 30 g leave-on cream is simple to target to a small cleaned lesion and can be covered, with no preparation or mg/kg calculation. Reliable licking prevention, site exclusions, dressing surveillance and the absence of a validated veterinary amount/frequency add meaningful but manageable burden.

Full-course cost-effectiveness-

A current 30 g Georgian tube price was verified, but lesion-area-adjusted total course use, dressing needs, wastage and comparable veterinary alternatives were not; price is excluded from the denominator.

Important safety and use flags

  • This score covers only adjunctive care of a cleaned small superficial skin wound with credible infection risk. It does not cover deep, puncture/bite, devitalised, heavily contaminated, abscessed, large-area or established infected wounds, pyoderma generally, surgical closure or burns requiring specialist care.
  • Bepanthen Plus is a human medicine and dog/cat use is off-label. No exact-product veterinary amount, frequency or course is established; do not copy the human up-to-four-times-daily label or another chlorhexidine product’s regimen.
  • Examine and clean the wound first. Deep pockets, devitalised tissue, foreign material, bite/puncture injury, exudate, spreading inflammation, fever, pain or poor healing requires drainage, debridement, culture, closure or systemic treatment as clinically indicated.
  • Keep away from eyes and periocular skin, mucosa and the ear canal when tympanic integrity is unknown. Chlorhexidine can cause severe corneal damage; ocular exposure requires immediate copious irrigation and urgent assessment if signs persist.
  • Prevent licking and ingestion until the site is protected or the cream is no longer accessible. Use a collar or secure nonconstrictive dressing when needed, and inspect for maceration, pressure, swelling, discharge or impaired circulation.
  • Stop immediately for increasing erythema, pruritus, pain, swelling, urticaria, facial swelling, breathing difficulty or another local/systemic hypersensitivity sign. Chlorhexidine can rarely cause anaphylaxis; lanolin, cetyl alcohol and stearyl alcohol can cause contact dermatitis.
  • Do not apply over a large area or continue frequent repeated use without review. Exact damaged-skin absorption and repeated-use tolerance are unknown, and canine cell data show concentration-dependent chlorhexidine cytotoxicity even when short healthy-skin exposure appears acceptable.
  • Do not combine on the same site with soaps/anionic compounds or another topical antiseptic without compatibility review. Organic debris can reduce topical antiseptic performance; cleaning and direct lesion contact matter.
  • Do not use antibacterial cream where infection risk is not credible merely to promote healing. Avoid unnecessary antiseptic exposure and choose a non-antiseptic wound/barrier product when that better matches the diagnosed lesion.
  • Safety in pregnant, lactating, breeding or juvenile dogs and cats is not established for repeated use on damaged skin. Make an explicit patient-specific benefit-risk decision and prevent neonate or littermate contact/ingestion.
Assessment sources
  1. Bepanthen Plus GE register2026
  2. Bepanthen Plus Lithuania register2026
  3. Bepanthen Plus HALMED leaflet2024
  4. Bepanthen Plus Aversi 30 g2026
  5. Malaseb dog/cat SPC2025
  6. ISCAID canine pyoderma guideline2025
  7. Canine daily chlorhexidine skin study2025
  8. Canine chlorhexidine wound study1992
  9. Canine antiseptic wound study2024
  10. Mixed-pet dexpanthenol ointment study2023
  11. Topical dexpanthenol review2002
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Adjunctive topical care of a cleaned small superficial skin wound or abrasion with credible infection risk, after exclusion or separate management of deep injury, established infection and wounds requiring debridement, drainage or closure
4.2/10
Weak evidence support
vetman assessment

Bepanthen Plus

dexpanthenol 50 mg/g + chlorhexidine dihydrochloride 5 mg/g, cream 30 g, human medicine
Assessed clinical scopeCat · Adjunctive topical care of a cleaned small superficial skin wound or abrasion with credible infection risk, after exclusion or separate management of deep injury, established infection and wounds requiring debridement, drainage or closure · On the skin
Care settingVeterinarian-directed outpatient or inpatient use on a small accessible lesion with planned licking prevention, wound monitoring and escalation if healing or infection control is inadequate
vetman score 4.2/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, human · № რ-038463 · Verified on 22 Oct 2026 Off-label use

A weak off-label option with greater uncertainty in cats. A different rinse-off feline chlorhexidine product and mixed-species dexpanthenol data do not resolve leave-on efficacy, grooming ingestion or exact-product tolerance; use only when exposure can be controlled and better-supported care is not displaced.

Regulatory and scientific credibility5.5/10

The exact 30 g human cream has transparent composition and current Georgian/EU human authorisation, and a different chlorhexidine rinse-off shampoo is authorised for cats. There is no exact-product feline dossier; salt, concentration, vehicle, wash-off versus leave-on use and disease scope differ materially.

Clinical efficacy3.5/10

No exact-product feline outcome trial was found. A rinse-off chlorhexidine/miconazole shampoo label and a small mixed-species study of a different 10% dexpanthenol/decamethoxine ointment offer only indirect class plausibility and cannot establish this leave-on cream’s benefit.

Safety and tolerability3.5/10

The rinse-off feline chlorhexidine label documents external-use, eye, licking and rare local-reaction precautions, but exact leave-on cream tolerance, damaged-skin exposure and grooming ingestion are unknown. Corneal injury and serious hypersensitivity are hard stops, and lanolin/cetyl/stearyl alcohol can cause contact dermatitis.

Clinical practicality4.5/10

Application to a small lesion is simple, but a grooming cat often requires a collar or secure nonconstrictive dressing, repeated handling and close skin checks. Eye/ear/mucosa exclusions and no validated feline amount/frequency materially reduce practicality.

Full-course cost-effectiveness-

A current 30 g Georgian tube price was verified, but lesion-area-adjusted total course use, dressing needs, wastage and comparable veterinary alternatives were not; price is excluded from the denominator.

Important safety and use flags

  • This score covers only adjunctive care of a cleaned small superficial skin wound with credible infection risk. It does not cover deep, puncture/bite, devitalised, heavily contaminated, abscessed, large-area or established infected wounds, pyoderma generally, surgical closure or burns requiring specialist care.
  • Bepanthen Plus is a human medicine and dog/cat use is off-label. No exact-product veterinary amount, frequency or course is established; do not copy the human up-to-four-times-daily label or another chlorhexidine product’s regimen.
  • Examine and clean the wound first. Deep pockets, devitalised tissue, foreign material, bite/puncture injury, exudate, spreading inflammation, fever, pain or poor healing requires drainage, debridement, culture, closure or systemic treatment as clinically indicated.
  • Keep away from eyes and periocular skin, mucosa and the ear canal when tympanic integrity is unknown. Chlorhexidine can cause severe corneal damage; ocular exposure requires immediate copious irrigation and urgent assessment if signs persist.
  • Prevent licking and ingestion until the site is protected or the cream is no longer accessible. Use a collar or secure nonconstrictive dressing when needed, and inspect for maceration, pressure, swelling, discharge or impaired circulation.
  • Stop immediately for increasing erythema, pruritus, pain, swelling, urticaria, facial swelling, breathing difficulty or another local/systemic hypersensitivity sign. Chlorhexidine can rarely cause anaphylaxis; lanolin, cetyl alcohol and stearyl alcohol can cause contact dermatitis.
  • Do not apply over a large area or continue frequent repeated use without review. Exact damaged-skin absorption and repeated-use tolerance are unknown, and canine cell data show concentration-dependent chlorhexidine cytotoxicity even when short healthy-skin exposure appears acceptable.
  • Do not combine on the same site with soaps/anionic compounds or another topical antiseptic without compatibility review. Organic debris can reduce topical antiseptic performance; cleaning and direct lesion contact matter.
  • Do not use antibacterial cream where infection risk is not credible merely to promote healing. Avoid unnecessary antiseptic exposure and choose a non-antiseptic wound/barrier product when that better matches the diagnosed lesion.
  • Safety in pregnant, lactating, breeding or juvenile dogs and cats is not established for repeated use on damaged skin. Make an explicit patient-specific benefit-risk decision and prevent neonate or littermate contact/ingestion.
Assessment sources
  1. Bepanthen Plus GE register2026
  2. Bepanthen Plus Lithuania register2026
  3. Bepanthen Plus HALMED leaflet2024
  4. Bepanthen Plus Aversi 30 g2026
  5. Malaseb dog/cat SPC2025
  6. Mixed-pet dexpanthenol ointment study2023
  7. Topical dexpanthenol review2002
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Dexpanthenol50 mg/g Chlorhexidine5 mg/g
Formulation Type
Cream
Administration route
On the skin
Manufacturer
GP Grenzach Produktions GmbH · Germany
Registration
Georgia Yes, human
In force until 28 Jun 2028
Human (Ministry of Health, RAMA)
№ რ-038463
Verified on: 22 Oct 2026
 EU Yes, human
Verified on: 16 Oct 2026
 UK No
Verified on: 16 Oct 2026
 US No
Verified on: 16 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified No exact-product dog/cat amount, frequency or course is established. Potential off-label use is limited to veterinarian-assessed, cleaned, small superficial skin wounds with infection risk. Prevent licking and use a secure nonconstrictive dressing or collar when needed. Do not copy the human up-to-four-times-daily direction or another chlorhexidine product’s regimen.

CitoDerm 42.4 mg/ml medicated shampoo with chlorhexidine, Solution

200 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Complete label: bacterial, fungal, mixed and atopic skin lesions; superficial/deep pyoderma; Malassezia/dermatophyte wording; flea/interdigital dermatitis; interdigital cystic folliculitis; and post-clipping prevention
6.4/10
Situational / acceptable
vetman assessment

CitoDerm

42.4 mg/ml medicated shampoo with chlorhexidine, 200 ml for dogs and cats
Assessed clinical scopeDog · Complete label: bacterial, fungal, mixed and atopic skin lesions; superficial/deep pyoderma; Malassezia/dermatophyte wording; flea/interdigital dermatitis; interdigital cystic folliculitis; and post-clipping prevention · On the skin
Care settingVeterinary-selected whole-body or local rinse-off treatment after dermatologic diagnosis; home application is possible with exact weighing, contact-time and licking/eye control
vetman score 6.4/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 000573 · Verified on 23 Oct 2026

A locally authorised chlorhexidine shampoo with meaningful canine class evidence for superficial bacterial and selected Malassezia disease, but no exact-product outcomes and a label far broader than the evidence. It is a useful diagnosis-led topical option, not stand-alone validation for deep infection, dermatophytosis, allergy or interdigital furunculosis.

Regulatory and scientific credibility6.5/10

The exact 200 ml dog/cat product has current Georgian authorisation and a reproducible manufacturer instruction, but the instruction has a blank registration field and no public exact-product regulator assessment. Exact EU/GB/US authorisation is absent; regulated chlorhexidine shampoos are formulation controls only.

Clinical efficacy5.5/10

Independent canine trials and ISCAID/WAVD guidance support 2-4% chlorhexidine shampoos for superficial bacterial and selected Malassezia disease. No exact CitoDerm trial was found, its contact time differs, and evidence does not validate the full deep-pyoderma, dermatophyte, atopy/flea or interdigital-furunculosis breadth.

Safety and tolerability7.0/10

Rinse-off chlorhexidine has low systemic exposure and chiefly local labelled reactions, but exact quantified target-animal, reproductive and repeat-course safety data are absent. Ocular, mucosal, ear/tympanic, ingestion, contact-allergy and damaged-tissue exposure require active control.

Clinical practicality6.5/10

The measured 0.5-1 ml/kg range, 5-7-minute contact and finite 3-4-week course are clear, and 200 ml is workable for many dogs. Whole-body wetting, massage, rinsing/drying every 3-7 days, variable coat demand and coordination with other topical products still create material workload.

Full-course cost-effectiveness-

Current Georgian per-course price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Complete-label boundary: this score includes superficial and deep pyoderma, bacterial/fungal/mixed and atopic lesions, Malassezia/dermatophyte wording, flea/interdigital dermatitis, interdigital cystic folliculitis and post-clipping prevention. Stronger superficial-disease evidence is not scored alone.
  • Evidence boundary: canine 2-4% chlorhexidine studies support superficial bacterial and selected Malassezia disease, but no exact CitoDerm trial validates its 5-7-minute contact, excipients or complete breadth. Deep pyoderma and interdigital furunculosis commonly need systemic/source-control care.
  • Diagnostic boundary: use cytology for bacterial/yeast disease; culture rods, deep/recurrent/unusual or failing infection; perform appropriate fungal testing; and investigate allergy, fleas/mites, endocrine/immune disease, foreign material and conformational causes before repeating treatment.
  • Exact regimen: wet the coat; apply 0.5-1 ml/kg; distribute and massage to foam; prevent eye contact and licking; rinse thoroughly after 5-7 minutes, comb and dry. Repeat every 3-7 days according to severity for 3-4 weeks; do not substitute comparator contact schedules.
  • Response/escalation: reassess superficial bacterial disease by 2-3 weeks. Systemic illness, pain, draining tracts, deep or rapidly progressive lesions, treatment failure or recurrence requires prompt re-evaluation, source control and systemic/other targeted therapy when indicated.
  • Disease distinction: dermatophytosis and Malassezia dermatitis are not synonyms despite the label parenthesis. Dermatophyte cure needs disease-specific testing, whole-coat/environment/in-contact control and often validated topical plus systemic therapy; atopy and flea allergy require cause control.
  • External skin/coat only: avoid eyes/conjunctiva, mouth, mucosa, ear canals, body cavities and deep ulcerated tissue. Chlorhexidine can seriously injure the eye and middle/inner ear; rinse accidental exposure immediately and urgently assess persistent ocular, hearing or vestibular signs.
  • Stop and rinse for hypersalivation, lacrimation, erythema, pruritus or worsening irritation. Consider hypersensitivity to chlorhexidine, propolis, fragrance or surfactants. Pregnancy, lactation and young animals require veterinary supervision; exact reproductive safety data are absent.
  • Combination boundary: adjunct treatment may be necessary, but exact compatibility was not studied. Anionic soaps/detergents can reduce chlorhexidine activity and frequent shampooing can alter some topical ectoparasiticide duration; deliberately sequence products and avoid casual stacking.
  • Practical/handler boundary: at the label range, 200 ml supplies 200-400 kg-total bodyweight per application, but coat and lesion extent change real use. Wear gloves for repeated treatment or dermatophytosis, avoid eyes/mouth, wash hands and disinfect equipment/environment.
Assessment sources
  1. CitoDerm GE register2026
  2. Ekoprom CitoDerm
  3. Clorexivet 4% control2026
  4. Malaseb VMD control2025
  5. ISCAID canine pyoderma 20252025
  6. WAVD Malassezia2020
  7. Chlorhexidine pyoderma RCT2010
  8. 4% chlorhexidine canine trial2015
  9. WAVD dermatophytosis2017
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Complete label: bacterial, fungal, mixed and atopic skin lesions; superficial/deep pyoderma; Malassezia/dermatophyte wording; flea/interdigital dermatitis; interdigital cystic folliculitis; and post-clipping prevention
5.6/10
Weak evidence support
vetman assessment

CitoDerm

42.4 mg/ml medicated shampoo with chlorhexidine, 200 ml for dogs and cats
Assessed clinical scopeCat · Complete label: bacterial, fungal, mixed and atopic skin lesions; superficial/deep pyoderma; Malassezia/dermatophyte wording; flea/interdigital dermatitis; interdigital cystic folliculitis; and post-clipping prevention · On the skin
Care settingVeterinary-selected whole-body or local rinse-off treatment after dermatologic diagnosis; home application is possible with exact weighing, contact-time and licking/eye control
vetman score 5.6/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000573 · Verified on 23 Oct 2026

A locally authorised feline shampoo with a clear regimen but no exact outcome programme and sparse direct feline chlorhexidine evidence. Broad infection/allergy claims, bathing burden and licking/ocular-aural risk make complete-label value weak unless diagnosis and adjunct treatment are explicit.

Regulatory and scientific credibility6.5/10

The exact 200 ml dog/cat product has current Georgian authorisation and a reproducible manufacturer instruction, but the instruction has a blank registration field and no public exact-product regulator assessment. Exact EU/GB/US authorisation is absent; regulated chlorhexidine shampoos are formulation controls only.

Clinical efficacy4.0/10

Exact feline authorisation and a recent different chlorhexidine-combination study provide limited plausibility, but consensus finds topical feline chlorhexidine evidence largely unsubstantiated. Canine trials cannot validate the broad cat label, deep disease, dermatophytosis or allergy claims.

Safety and tolerability6.5/10

Low systemic exposure is favourable, but feline exact safety outcomes are absent and grooming/ingestion plus ocular or aural transfer are more consequential. Salivation, lacrimation, irritation, component allergy and restraint stress require prevention and prompt rinsing.

Clinical practicality5.5/10

The regimen is explicit, but repeated whole-body wetting, restraint, 5-7-minute licking prevention, thorough rinsing and drying are commonly harder in cats. Cooperation, welfare and accidental ingestion can limit adherence; a local cotton-pad technique does not remove diagnostic or environmental work.

Full-course cost-effectiveness-

Current Georgian per-course price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Complete-label boundary: this score includes superficial and deep pyoderma, bacterial/fungal/mixed and atopic lesions, Malassezia/dermatophyte wording, flea/interdigital dermatitis, interdigital cystic folliculitis and post-clipping prevention. Stronger superficial-disease evidence is not scored alone.
  • Feline evidence boundary: exact local authorisation does not equal demonstrated outcomes. Consensus finds topical feline chlorhexidine evidence sparse; a recent different chlorhexidine/Ophytrium study and canine trials cannot validate CitoDerm or its full cat label.
  • Diagnostic boundary: use cytology for bacterial/yeast disease; culture rods, deep/recurrent/unusual or failing infection; perform appropriate fungal testing; and investigate allergy, fleas/mites, endocrine/immune disease, foreign material and conformational causes before repeating treatment.
  • Exact regimen: wet the coat; apply 0.5-1 ml/kg; distribute and massage to foam; prevent eye contact and licking; rinse thoroughly after 5-7 minutes, comb and dry. Repeat every 3-7 days according to severity for 3-4 weeks; do not substitute comparator contact schedules.
  • Response/escalation: reassess superficial bacterial disease by 2-3 weeks. Systemic illness, pain, draining tracts, deep or rapidly progressive lesions, treatment failure or recurrence requires prompt re-evaluation, source control and systemic/other targeted therapy when indicated.
  • Disease distinction: dermatophytosis and Malassezia dermatitis are not synonyms despite the label parenthesis. Dermatophyte cure needs disease-specific testing, whole-coat/environment/in-contact control and often validated topical plus systemic therapy; atopy and flea allergy require cause control.
  • External skin/coat only: avoid eyes/conjunctiva, mouth, mucosa, ear canals, body cavities and deep ulcerated tissue. Chlorhexidine can seriously injure the eye and middle/inner ear; rinse accidental exposure immediately and urgently assess persistent ocular, hearing or vestibular signs.
  • Stop and rinse for hypersalivation, lacrimation, erythema, pruritus or worsening irritation. Consider hypersensitivity to chlorhexidine, propolis, fragrance or surfactants. Pregnancy, lactation and young animals require veterinary supervision; exact reproductive safety data are absent.
  • Combination boundary: adjunct treatment may be necessary, but exact compatibility was not studied. Anionic soaps/detergents can reduce chlorhexidine activity and frequent shampooing can alter some topical ectoparasiticide duration; deliberately sequence products and avoid casual stacking.
  • Cat practicality/handler boundary: assess whether repeated whole-body restraint, wetting, 5-7-minute contact, rinsing and drying are humane and achievable. Prevent grooming/ingestion until fully rinsed and dry; use gloves for dermatophytosis and clean equipment/environment.
Assessment sources
  1. CitoDerm GE register2026
  2. Ekoprom CitoDerm
  3. Clorexivet 4% control2026
  4. Malaseb VMD control2025
  5. ISCAID canine pyoderma 20252025
  6. WAVD Malassezia2020
  7. Chlorhexidine pyoderma RCT2010
  8. WAVD dermatophytosis2017
  9. Feline chlorhexidine study2025
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Chlorhexidine42.4 mg/ml
Formulation Type
Solution
Administration route
On the skin
Manufacturer
JSC NPF Ekoprom
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1030, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 21 Mar 2029
Veterinary (National Food Agency)
In the register: ციტოდერმი 42.4 მგ/მლ, 200 მლ ძაღლისა და კატისთვის
№ 000573
Verified on: 23 Oct 2026
 EU No
Verified on: 23 Oct 2026
 UK No
Verified on: 23 Oct 2026
 US No
Verified on: 23 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified Complete label: bacterial, fungal/mixed and atopic skin lesions, superficial/deep pyoderma, Malassezia/dermatophyte wording, flea/interdigital dermatitis and post-clipping complication prevention. Wet coat; apply 0.5-1 ml/kg; foam; prevent eye contact/licking; rinse after 5-7 minutes; repeat every 3-7 days for 3-4 weeks. Diagnose and treat the underlying disease; broad/deep claims are not equally validated.

Diamond Eyes, Drops (oral)

eye drops 0.15/20/1 mg/ml, 10 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label: daily eye hygiene and mild conjunctivitis, cleaning discharge and instilling 1 drop (up to 10 kg) or 2 drops (over 10 kg) 1-3 times daily
4.8/10
Weak evidence support
vetman assessment

Diamond Eyes

eye drops 0.15/20/1 mg/ml, 10 ml for dogs and cats
Assessed clinical scopeDog · Full dog label: daily eye hygiene and mild conjunctivitis, cleaning discharge and instilling 1 drop (up to 10 kg) or 2 drops (over 10 kg) 1-3 times daily · Into the eye
Care settingOwner eye care after veterinary examination, for mild cases without corneal damage
vetman score 4.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000643 · Verified on 21 Oct 2026

A weak product: a mild antiseptic eye-cleansing drop with no proven treatment effect. Suitable for wiping away discharge, not for treating eye disease.

Regulatory and scientific credibility3.5/10

The exact product is registered in Georgia (000643, valid to 2029) with a current AVZ instruction; it has no international authorisation or independent study, and taurine and succinic acid have no evidence as eye treatments.

Clinical efficacy3.0/10

Dilute chlorhexidine (0.015%) gives some antiseptic cleansing, but no study shows that the product treats conjunctivitis, and true bacterial conjunctivitis needs an ophthalmic antibiotic.

Safety and tolerability6.5/10

The chlorhexidine concentration is low and the label sets maximum courses with breaks; chlorhexidine can irritate a damaged cornea, so ulcers should be excluded first.

Clinical practicality7.0/10

Simple drops with a clear dose and course schedule are easy for owners to use.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Examine and stain the eye first; persistent discharge, squinting or a red eye needs diagnosis, not cleansing drops.
  • Respect the maximum courses: 45 days once daily, 20 days twice daily or 14 days three times daily, each followed by a break.
  • Leave at least 5 minutes between this product and other eye medicines.
  • Taurine and succinic acid have no proven eye benefit; do not rely on this product for infection.
  • Use in pregnancy and in newborns needs veterinary benefit-risk assessment.
Assessment sources
  1. AVZ Diamond Eyes2026
  2. Georgia NFA register 20262026
  3. Merck ophthalmic antimicrobials2025
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label: daily eye hygiene and mild conjunctivitis, cleaning discharge and instilling 1 drop 1-3 times daily
4.8/10
Weak evidence support
vetman assessment

Diamond Eyes

eye drops 0.15/20/1 mg/ml, 10 ml for dogs and cats
Assessed clinical scopeCat · Full cat label: daily eye hygiene and mild conjunctivitis, cleaning discharge and instilling 1 drop 1-3 times daily · Into the eye
Care settingOwner eye care after veterinary examination, for mild cases without corneal damage or active herpesvirus disease
vetman score 4.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000643 · Verified on 21 Oct 2026

A weak product for cats: a mild antiseptic eye-cleansing drop with no proven treatment effect. Feline conjunctivitis needs a diagnosis and specific therapy.

Regulatory and scientific credibility3.5/10

The exact product is registered in Georgia (000643, valid to 2029) with a current AVZ instruction; it has no international authorisation or independent study, and taurine and succinic acid have no evidence as eye treatments.

Clinical efficacy3.0/10

Dilute chlorhexidine gives some antiseptic cleansing, but no study shows that the product treats feline conjunctivitis, which is mostly viral or chlamydial and needs specific treatment.

Safety and tolerability6.5/10

The chlorhexidine concentration is low and the label sets maximum courses with breaks; chlorhexidine can irritate a damaged cornea, so ulcers should be excluded first.

Clinical practicality7.0/10

Simple single drops with a clear course schedule are easy for owners to use.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Examine and stain the eye first; squinting, a red eye or herpetic ulcers need diagnosis and specific treatment, not cleansing drops.
  • Respect the maximum courses: 45 days once daily, 20 days twice daily or 14 days three times daily, each followed by a break.
  • Leave at least 5 minutes between this product and other eye medicines.
  • It does not treat feline herpesvirus or Chlamydia felis.
  • Use in pregnancy and in newborn kittens needs veterinary benefit-risk assessment.
Assessment sources
  1. AVZ Diamond Eyes2026
  2. Georgia NFA register 20262026
  3. ABCD 20262026
  4. ABCD Chlamydia felis guideline2026
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Chlorhexidine0.15 mg/ml Taurine20 mg/ml Succinic acid1 mg/ml
Formulation Type
Drops (oral)
Administration route
Into the eye
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1138, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 01 May 2029
Veterinary (National Food Agency)
In the register: თვალის წვეთები ბრილიანტის თვალები
№ 000643
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

OKVET 5% chlorhexidine medicated shampoo, Topical (unspecified)

250 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label: 5% chlorhexidine medicated shampoo course for diagnosed bacterial and related skin infections, alone or with systemic therapy
6.0/10
Situational / acceptable
vetman assessment

OKVET

5% chlorhexidine medicated shampoo, 250 ml for dogs and cats
Assessed clinical scopeDog · Full dog label: 5% chlorhexidine medicated shampoo course for diagnosed bacterial and related skin infections, alone or with systemic therapy · On the skin
Care settingHome bathing course after a veterinary skin diagnosis, with recheck at the end of the course
vetman score 6.0/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000982 · Verified on 21 Oct 2026

A situational topical antiseptic: chlorhexidine bathing is a guideline-backed option for superficial pyoderma, but this 5% product lacks its own data. Confirm the diagnosis and keep it out of eyes and ears.

Regulatory and scientific credibility5.0/10

Registered in Georgia (000982, valid to 2030) with a current maker instruction; chlorhexidine is a well-studied antiseptic, but this shampoo has no EU, UK or US authorisation documented in the reviewed evidence or product-specific study.

Clinical efficacy6.0/10

ISCAID guidance supports chlorhexidine shampoo as sole or adjunctive therapy for superficial pyoderma; this formulation is untested, and chlorhexidine alone is not recommended for dermatophytosis.

Safety and tolerability7.0/10

Chlorhexidine shampoo is generally well tolerated on skin, but 5% is stronger than the usual 2-4%, it can irritate, damages the cornea on eye contact and is ototoxic if it reaches the middle ear.

Clinical practicality6.0/10

1 ml/kg every 3-5 days for 3-4 weeks with 5-10 minutes contact is standard antiseptic bathing, but it is labour-intensive and a 250 ml bottle covers few baths in a large dog.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Keep out of the eyes and ear canals: chlorhexidine can injure the cornea and is ototoxic if the eardrum is not intact.
  • Deep pyoderma needs systemic antimicrobials chosen by culture; use the shampoo as an adjunct there.
  • For ringworm, chlorhexidine alone is not enough: use a miconazole-chlorhexidine or lime sulfur product with systemic antifungals.
  • Stop if redness, itching or scaling worsens after bathing.
  • Leave on for 5-10 minutes, rinse thoroughly and dry; hard water reduces chlorhexidine activity.
Assessment sources
  1. AVZ OKVET shampoo2026
  2. Georgia NFA register 20262026
  3. ISCAID pyoderma 20252025
  4. WAVD dermatophytosis consensus2017
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label: 5% chlorhexidine medicated shampoo course for diagnosed bacterial and related skin infections, alone or with systemic therapy
5.2/10
Weak evidence support
vetman assessment

OKVET

5% chlorhexidine medicated shampoo, 250 ml for dogs and cats
Assessed clinical scopeCat · Full cat label: 5% chlorhexidine medicated shampoo course for diagnosed bacterial and related skin infections, alone or with systemic therapy · On the skin
Care settingBathing course after a veterinary skin diagnosis, in a cat that tolerates bathing, with recheck at the end of the course
vetman score 5.2/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000982 · Verified on 21 Oct 2026

A weak option for cats: chlorhexidine is a sound antiseptic, but repeated bathing is hard for most cats and this 5% product lacks its own data. Consider local wipes or sprays where suitable.

Regulatory and scientific credibility5.0/10

Registered in Georgia (000982, valid to 2030) for dogs and cats with a current maker instruction; chlorhexidine is a well-studied antiseptic, but this shampoo has no EU, UK or US authorisation documented in the reviewed evidence or product-specific study.

Clinical efficacy5.0/10

Chlorhexidine is an effective topical antiseptic, but evidence for shampoo therapy in cats is thinner than in dogs, this formulation is untested, and chlorhexidine alone is not recommended for dermatophytosis.

Safety and tolerability6.0/10

Generally tolerated on skin, but 5% is stronger than the usual 2-4%, cats may ingest residue while grooming, and eye or middle-ear contact can cause corneal injury or ototoxicity.

Clinical practicality4.5/10

Bathing a cat every 3-5 days for 3-4 weeks with 5-10 minutes contact is stressful and often not feasible.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Keep out of the eyes and ear canals: chlorhexidine can injure the cornea and is ototoxic if the eardrum is not intact.
  • Rinse thoroughly and dry fully so the cat does not lick off residue; stop if drooling, redness or itching appears.
  • For ringworm, chlorhexidine alone is not enough: use a miconazole-chlorhexidine or lime sulfur product with systemic antifungals.
  • Repeated bathing is stressful for many cats; plan low-stress handling or choose another topical form.
  • Leave on for 5-10 minutes, rinse thoroughly and dry; hard water reduces chlorhexidine activity.
Assessment sources
  1. AVZ OKVET shampoo2026
  2. Georgia NFA register 20262026
  3. WAVD dermatophytosis consensus2017
  4. AAFP ISFM cat handling2022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Chlorhexidine50 mg/ml
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1552, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
In force until 31 Oct 2030
Veterinary (National Food Agency)
In the register: ოკვეტი® სამკურნალო შამპუნი ქლორჰექსიდინით 5%
№ 000982
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗